Limeciclina Atral (Lymecycline)

Lymecycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. This prevents the attachment of aminoacyl‑tRNA to the ribosome, halting the production of essential proteins and producing a bacteriostatic effect against Cutibacterium acnes, the organism implicated in acne.

The dosage of Limeciclina Atral is determined by the prescribing clinician based on the patient’s age, severity of acne, and individual health considerations. Physicians tailor the regimen to achieve optimal therapeutic effect while minimizing potential adverse reactions.

Limeciclina Atral is classified as Pregnancy Category D, indicating evidence of risk to the fetus, and it is generally contraindicated in pregnancy. It is also not recommended during breastfeeding because the drug can be excreted in breast milk and may affect the infant.

To order Limeciclina Atral, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lymecycline belongs to the tetracycline class and offers a similar spectrum of activity to doxycycline and minocycline. Compared with doxycycline, lymecycline often requires a lower daily dose because of its higher bioavailability, while minocycline may have a higher risk of vestibular side effects. Choice depends on patient tolerance, drug‑interaction profile, and physician preference.

Store Limeciclina Atral at ambient temperature below 25 °C. Keep the tablets in the original container, protect them from moisture and direct light, and ensure the packaging remains tightly closed until use.

Limeciclina Atral is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid simultaneous intake of antacids or mineral supplements that may interfere with absorption.

Serious adverse reactions, although rare, include hepatotoxicity, severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, pseudotumor cerebri (increased intracranial pressure), and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience symptoms like jaundice, rash, severe headache, or persistent diarrhea.

Limeciclina Atral should be avoided in pregnant women, nursing mothers, children younger than eight years, and patients with known hypersensitivity to tetracyclines. Individuals with severe renal impairment should also be evaluated carefully before use.